Earn 15+ CPD credits while staying current with the latest advances.
Register 3+ colleagues and unlock 20% team discount.
Publish your findings in collaborated journals and receive exclusive discounts.
The International Conference on Addiction Medicine, Mental Health and Psychiatry (ICAMP 2026) will be held from March 23-25, 2026, in Singapore and Online. This conference will bring together leading psychiatrists, psychologists, addiction specialists, researchers, healthcare professionals, and industry experts from around the world to discuss the latest advancements in mental health, addiction medicine, and psychiatric research. Key highlights include keynote presentations, scientific sessions, workshops, and networking opportunities, covering topics such as substance use disorders, behavioral addictions, mental health therapies, neuroscience of addiction, and emerging treatment modalities. ICAMP 2026 is a vital event for professionals dedicated to improving mental health and addiction care, fostering collaboration and innovation in addressing global challenges in psychiatry and addiction medicine.
ICAMP 2026 will also feature interactive panel discussions and poster presentations, offering participants the opportunity to explore new perspectives and exchange ideas on emerging trends and challenges in mental health and addiction treatment. The event will provide a platform for showcasing cutting-edge research, therapeutic approaches, and innovative technologies, fostering collaboration between researchers, clinicians, and industry leaders. Attendees will have the chance to engage in meaningful discussions, build professional networks, and explore potential partnerships, all contributing to the shared goal of advancing mental health and addiction medicine for a healthier global community.
Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
The Mathews Journal of Psychiatry & Mental Health is proud to serve as the supporting journal for this upcoming event on Addiction Medicine, Mental Health and Psychiatry. As part of this collaboration, a DOI will be assigned to the conference proceedings book, ensuring the research and findings presented at the event are globally accessible and citable. Additionally, participants who wish to publish their full-length research articles have the opportunity to submit their manuscripts for consideration in the Mathews Journal of Psychiatry & Mental Health. This is an excellent platform for researchers and professionals to share their contributions to the field, receive peer-reviewed recognition, and enhance the visibility of their work.&n...
Addiction Medicine, Mental Health & Psychiatry
$410B
2023 → $573B by 2033
$10.1B
2025 → $15B by 2032
$22.9B
CAGR: 18.4%
Telepsychiatry, CBT apps, and AI chatbots—topics already dominating Addiction Medicine Conference —dramatically widen access and reduce wait-times.
+24%FDA Breakthrough designations for CYB003 and MDMA protocols are headline panels at the next Psychiatry Conferences 2026, signalling a paradigm shift in treating SUD and depression.
BreakthroughValue-based contracts that link addiction care with primary and specialty services will feature prominently at Mental Health Conferences, advancing truly holistic models.
+15%Wearables, digital phenotyping, and pharmacogenomics—hot topics across leading Addiction Conferences 2026—enable precision dosing, relapse prediction, and individualized care pathways.
+32%| Segment | 2024-25 Value | 2030-34 Forecast | CAGR % | Key Insight |
|---|---|---|---|---|
| USD 22.9B | ≈ USD 53B | 18.4% | Pandemic-accelerated adoption | |
| USD 10.1B | ≈ USD 15B | 5.8% | Alcohol & opioid therapies lead | |
| USD 3.44B | ≈ USD 7B | 8.2% | Psychedelic & digital-therapeutic focus |
Deuterated formulation delivers greater metabolic stability and potentially longer therapeutic windows—key data to be unpacked at the Addiction Medicine Conference psychedelic track.
Machine-learning triage tools already outperform legacy questionnaires, accelerating early diagnosis—a core focus across Psychiatry Conferences 2026.
Real-time feedback cuts treatment sessions by 50 %, enabling broader access—slated for live demos during Mental Health Conferences technology symposia.
Virtual-reality cue-reduction programs improve retention by ≈ 30 %, offering scalable adjuncts for relapse prevention—featured in interactive labs at upcoming Addiction Conference.
Mental-health startups raised $1.13B in 2024, with Series C rounds led by digital-therapeutic and tele-addiction platforms.
Gardens by the Bay
Marina Bay Sands
Merlion Park
Sentosa Island
Copyright 2024 Mathews International LLC All Rights Reserved
